Thanks to the efforts of R&D Center, the company's dermatological drugs won the contribution award for the development of dermatology and the contribution award for the development of burn surgery. With its strong R&D strength, the company has been recognized as a national high-tech enterprise, undertaken the development of many national and municipal torch programs such as the micro-powder oil gel detoxification burn ointment project, and set up the only research and development center of TCM dermatology engineering technology in the postdoctoral research mobile station and Guangdong Province.
The imperial prescriptions, prescriptions and pharmacology collected by the time-honored brand "Tai 'antang" with a history of nearly 500 years are priceless treasures for the development of modern proprietary Chinese medicines.
In order to carry forward the essence of Chinese medicine and develop the cause of Chinese medicine, the company pays attention to extracting the essence from Chinese medicine, carries out the modernization of Chinese medicine in depth, realizes the organic combination of Chinese medicine theory and modern medicine, and develops new products of modern Chinese medicine and natural medicine by using modern pharmaceutical technology. High-end joint Chinese Academy of Traditional Chinese Medicine, China Academy of Sciences, Chinese Medical Association and other national research institutions, as well as national famous dermatologists and experts in traditional Chinese medicine, form a team of senior enterprise technology consultants, and join famous institutions of higher learning such as Shanghai Medical Engineering College, Sun Yat-sen University, Chengdu University of Traditional Chinese Medicine and Guangzhou University of Traditional Chinese Medicine to take the road of combining Industry-University-Research, and strive to build postdoctoral workstations and R&D centers into well-known domestic platforms for modern traditional chinese medicine's innovation and technological achievements industrialization. As a national high-tech enterprise, the company will continue to develop the R&D institution system, improve the R&D software and hardware environment, increase investment in scientific research, and apply to the National R&D Center on the basis of establishing the Guangdong R&D Center of TCM Dermatology Engineering Technology.
The company will actively take the road of modernization and industrialization of traditional Chinese medicine, strengthen cooperation with national key universities and scientific research institutions, and establish a benign and interoperable technical information sharing platform for the company.
In addition, the company will build a three-dimensional R&D network hub, establish a large pattern system of Chinese patent medicine products, build a new product R&D chain, give full play to the role of postdoctoral research center, and embark on a benign development track of "producing one generation, reserving one generation, developing one generation and aiming at one generation". (1) National Torch Program Project: Micro-powder Oil Gel Detoxification Burn Cream;
(2) The third-class national new drug: Shezhi Fu Bing Ointment has completed the third-phase clinical trial;
(3) Products of the Ministry of Health of the People's Republic of China: Beibei Bao brand disinfection emulsion and Beibei Bao brand skin care freckle cream;
(4) Five national invention patents: "ZL92/KOOC-0/069/KOOC-0/5.4", "ZL2004/KOOC-0/0077500./KOOC-0/"and "ZL2005/KOOC-0/0/KOOC-" Comprehensively strengthen technical exchanges and cooperation with universities and research institutes, build a modern R&D three-dimensional network hub of Taian Tang, and comprehensively improve the overall scientific and technological level of enterprises. In recent years, foreign cooperation projects mainly include:
(1) In 2002, it signed the patent right of "a preparation method of wet wound burn ointment" and the new drug technology transfer agreement of "Jiedu burn ointment" with the Fourth People's Hospital of Zhuzhou City, Hunan Province, and completed the examination and approval of new drug technology transfer, obtained the product patent right, and put the product on the market in 2003.
(2) In 2002, we cooperated with Guangzhou University of Chinese Medicine to carry out basic research on pharmacology and toxicology of loquat cream products;
(3) In 2002, we cooperated with Guangzhou Red Cross Hospital and Nanjing Institute of Dermatology of China Academy of Sciences to carry out the clinical observation of PayPal Xiaoyan Xuan Shi Ointment.
(4) In 2003, in cooperation with Guangzhou University of Chinese Medicine, the skin irritation allergic test of enoxacin ointment was conducted.
(5) In 2003, the "Chinese Medicine Antifungal Seminar" was jointly held with the Dermatology Branch of Guangdong Branch of Chinese Medical Association.
(6) In 2004, in cooperation with Guangzhou University of Chinese Medicine, the skin irritation allergy test of compound ketoconazole hair cream was conducted.
(7) In 2004, we cooperated with Guangzhou University of Chinese Medicine to carry out skin irritation and allergy test of compound ketoconazole ointment.
(8) In 2004, we cooperated with Jinan University to develop a new national scientific and technological achievement-a new gynecological gel drug project of recombinant human basic fibroblast growth factor.
(9) In 2004, we cooperated with Jinan University to develop a new national scientific and technological achievement-a new drug project of recombinant human basic fibroblast growth factor eye drops for external use.
(10) In 2004, we cooperated with Guangzhou University of Chinese Medicine to observe and study the pharmacology and toxicology of three new drugs, Pipao Cream.
(11) In 2004, we cooperated with the Pharmacology Laboratory of Traditional Chinese Medicine of Guangzhou University of Traditional Chinese Medicine to conduct toxicological research on Xiaoyan Xuangypsum.
(12) In 2005, we cooperated with the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine to carry out the toxicological observation and research on the snake fat ice cream project.
(13) In 2005, we cooperated with the Affiliated Hospital of Sun Yat-sen Medical University to carry out the clinical study of Jiedu Burn Ointment.
(14) In 2006, we cooperated with the Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, the Affiliated Hospital of guangxi university of chinese medicine Cooperation, the Fujian Institute of Traditional Chinese Medicine and the Zhejiang Provincial Hospital of Traditional Chinese Medicine to carry out the second phase of clinical observation and research on snake fat ice skin ointment. (15) From 2006 to 2007, we cooperated with the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, the Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, the Affiliated Hospital of guangxi university of chinese medicine Cooperation, the Fujian Institute of Traditional Chinese Medicine, and the Zhejiang Provincial Hospital of Traditional Chinese Medicine to conduct the Phase III clinical study of Snake Fat Ice Skin Ointment.
(16) In 2006, we cooperated with the Pharmacology Research Office of Traditional Chinese Medicine of Guangzhou University of Traditional Chinese Medicine to study the pharmacodynamics and toxicology of Keyang Minyi and Jiere Xiaoyan Capsules.
(17) In 2006, we conducted an experimental study on the skin allergy and irritation of Xiaoyan Xuan Shi Ointment in cooperation with the Chinese Medicine Pharmacology Laboratory of Guangzhou University of Traditional Chinese Medicine.
(18) In 2006, we cooperated with the New Drug Development and Research Center of Guangzhou University of Traditional Chinese Medicine to conduct a pharmaceutical pilot study of Shezhi Fu Bing Ointment.
(19) In 2006-2007, we cooperated with Guangdong Quality Research Institute (Guangdong Institute for Drug Control) to improve the quality standards of Jiere Xiaoyan Capsule, Keyangmin Clothing and Xiaoyan Xuan Shi Ointment.
(20) In 2007, we cooperated with Sun Yat-sen University to study the quality standards of Chinese herbal medicines. Actively carry out the declaration of national, provincial and municipal key science and technology projects. In recent years, the projects include:
(1) In 2003, "Deep development of loquat paste" was listed as the torch project of Shantou City.
(2) In 2005, "Micro-powder snake fat ice cream" was listed as the Guangdong Torch Project.
(3) In 2005, "Micro-powder snake fat ice cream" was listed as Shantou Torch Project.
(4) In 2006, "Powder Oil Gel Detoxification Burn Ointment" was listed as the torch project of Shantou City.
(5) In 2007, "Study on Compound Venenum Bufonis Ointment, a new cancer analgesic drug" was listed as a key industrial project in Shantou.
(6) In 2007, "Micro-powder oil gel detoxifying burn ointment" was included in the national torch plan project.
(7) In 2008, "Kirin Pill" and "Xinbao Pill" were applied to be included in the key scientific and technological projects of Guangdong Province. Based on the long-term, the company attaches great importance to product R&D investment, improves its own R&D level, and absorbs the technological achievements of other scientific research institutions through introduction and cooperation, so that the company's R&D level has reached a higher level. At the same time, the company has made R&D work more systematic and standardized by formulating a series of R&D management systems, such as Guangdong Taiantang Pharmaceutical Co., Ltd. Technical Innovation Management System, New Product Development Management System, Technical Achievement Management Measures and Technical R&D Award Regulations.